Figure 1.

Probability of remaining alive at (a) 1 year and (b) 5 years by most efficacious treatment modality received in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B disease. (a) Kaplan–Meier curves indicate that the use of aggressive therapy confers a statistically significant survival benefit compared with the use of locoregional therapies (LRTs) at 1 year among patients with BCLC stage B disease. (b) Patients who underwent hepatic resection achieved a statistically significant increase in the probability of remaining alive at 5 years compared with those undergoing LRTs